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Background: The purpose is to assess cardiopulmonary function outcomes and quality of life values in inactive
people that participated in the Physical Activity Promotion Programme (PAPP) against the control group that did
not perform this program.
Method: A total of 100 subjects of both genders participated in the randomized controlled trial with systematic
random sampling; all were aged 55 and older, from Torremolinos, Spain. Participants either received (n = 50) the
PAPP for 60 minutes, twice a week during three months or (n = 50) they received health education. The
effectiveness of the intervention was measured by general state of health the Short Form 12 health survey
questionnaire, and the quality of life was determined with the EuroQoL-5D questionnaire. Cardiopulmonary
function was measured with a spirometry and a walking test according to the Bruce protocol.
Results: This pilot study had a significant impact on the quality of life (p = 0.05) in men, which increased. However,
the quality of life in women did not improve. The average changes in the lung and cardiovascular function was not
significant between groups.
Conclusions: Changes in the quality of life measured with EQ-5D in the group of men who carried out the PAPP
were statistically significant when comparing between groups. However changes in cardiopulmonary function were
not as relevant when comparing between groups. There was a significant effect within each group in the
pulmonary outcomes of values in men, within the experimental group.
Trial registration: Developed by the University of Málaga. ClinicalTrials.gov ID: NCT01172483.
Keywords: Promotion physical activity, Cardiopulmonary, Quality of lifeBackground
Prospective observational studies have suggested that in-
active people have more death risk due to no specific
cause and from specific diseases (e.g., cardiovascular dis-
ease, diabetes, obesity and others) associated with phys-
ical inactivity [1]. There is evidence that regular physical
activity contributes to the primary and secondary pre-
vention of several chronic diseases and is associated with
a reduced risk of premature death [2].* Correspondence: rovalemas@gmail.com
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distribution, and reproduction in any mediumHealth-related quality of life is an important measure
of the effect of an intervention program on cardiovascu-
lar disease [3]. There are studies in inactive people
which have observed a decrease in lung function [4].
Forced expiratory volume in one second (FEV1) was
used in the cohort study of Buffalo as a predictor of sur-
vival and as a tool to assess the overall health of the
population [5].
Epidemiological studies have showed that physical ac-
tivity has a protective effect towards cardiovascular dis-
ease [6]. The physical activity helps to regulate the blood
pressure [7]. There are previous studies about the physi-
cian’s role in promoting physical activity [8]. However, itentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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activity for inactive people in the Primary Healthcare
Centers.
The aim of the current study was to evaluate the effec-
tiveness of the Physical Activity Promotion Programme
(PAPP) on the quality of life and cardiopulmonary out-
comes for the inactive subjects compared with people
receiving education and advice in Primary Healthcare
Centers. Therefore this study compares the observed
changes in both the quality of life and cardiopulmonary
outcomes for people who participated in the PAPP and
those that did not carry out it.Methods
Study design and participants
The design was a randomized controlled pilot clinical
trial.
One hundred people from Primary Healthcare Centers
in Málaga begun this research and seventy-five subjects
completed the study. The age of the participants of both
genders ranged between 57 and 69.Inclusion and exclusion criteria
The General Practitioner selected the participants who
co-operated with the study. The criteria to be included
in the study were inactive people, not engaged, with
moderate physical activity for at least thirty minutes, five
times a week [9]. Participants also had to have three or
more of the following cardiovascular risk factors:
increased blood pressure 140/90, smoking, cholesterol
above 230 mg / dl, a family member that had suffered a
heart attack before the age of 55 if male or before the
age of 65 if female and an obese or overweight (more
than 8 kg) insulin-dependent diabetic [10].
The criteria to be excluded from participation in the
study were the following: infectious processes, malig-
nancy, metastasis, osteoporosis, inflammatory arthritis
or fractures, cognitive impairment due to any cause [11].Randomization
The people who would participate in this study were
randomized systematic procedures during the recruit-
ment period. Random sequence generation was per-
formed; people had to take a closed envelope from a box
in order to form part of the intervention group or the
control group. All the subjects who met the inclusion
criteria had to carry out an initial evaluation before
starting the procedure and at the end of twelve weeks
the same procedure was carried out. The researcher,
who did the evaluation, did not know what subjects
would be assigned to each group.Procedure
Physical activity promotion programme (PAPP)
The intervention group (IG) performed a PAPP twice a
week for twelve weeks, following the criteria of the
American College of Sports Medicine [9] in the Sports
and Physical Medical Center in Torremolinos. An
assigned professional health specialist carried out the
procedure between October and March of 2010 and
2011. Each session lasted 60 minutes, and all protocols
were developed for progressive intensity, depending on
each person. The sessions were organized at the early
stage of heating, followed by the aerobic phase and the
cooling-stretch or final phase.
Control group (CG)
The control group received an educational health leaflet
containing advice from Primary Healthcare Centers in
Málaga, and continued with their daily routine activities.
Subjects were assessed on the outcome measures at
baseline, at twelve weeks follow-up by an independent
blind assessor, at the Sports and Physical Medical Center
in Torremolinos, Spain.
Outcome measures
The primary outcomes were the following: General Health
Questionnaire determined with the Short Form-12 Health
Survey (SF-12) and Health-related Quality of Life
(HRQOL), determined with the EuroQoL-5D (EQ-5D).
The SF-12 questionnaire is a shortened version of the
SF-36, and has a reliability coefficient of 0.97 [12]. We
report the results of eight general health dimensions:
physical functioning, physical role, body pain, general
health, vitality, social functioning, emotional role and
mental health [13]. These eight dimensions can also be
used to generate both physical and mental health sum-
mary scores [12]. The SF-12 questionnaire will prove to
be a practical alternative to the SF-36, in order to meas-
ure the overall health of the population, because of the
high degree of correspondence between estimated phys-
ical and mental health measures, using the SF-12 and
SF-36 questionnaires [14].
The EQ-5D has five domains: mobility, self-care, usual
activities, pain, and anxiety/depression [15]. Each do-
main has three possible levels indicating; no problems,
moderate problems or severe problems [16]. The EQ-5D
valuation questionnaire comprises a visual analogue
scale which was not included in this research. It has
shown to be a acceptable and valid tool, with an average
estimation of 0.87 [17].
The secondary outcomes were cardiopulmonary. The
cardiac outcomes were at resting heart rate, and
achieved at the end of the test. Subjects were question-
naire about the rate perceived effort (RPE) several times
during the exercise test [18]. The pulmonary outcomes
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forced expiratory volume in one second and forced vital
capacity (FEV1/FVC), forced vital capacity (FVC) and
forced expiratory volume in one second (FEV1). The
values were expressed in absolute terms in milliliters
and as percentage of theoretical value for individuals of
the same age, weight and height in the reference
population.The exercise test
Subjects performed an exercise test on a treadmill
according to the Bruce protocol [19]. The sub maximal
protocol was used for the exercise test in which the sub-
ject would be over 85% of the maximum frequency. The
test was brought to an end when the subject reached
the maximum achievable intensity, taking into account
the following criteria: the theoretical maximum heart
rate according to age, usually calculated as two hun-
dred twenty minus age in years.
Participants were asked to identify their perception
of perceived exertion every thirty seconds and end the
test with the scale of effort adapted by Borg (RPE)
from zero to ten points [18]. The scale of the effort
perception was defined as the subjective intensity of
effort, stress, discomfort and / or fatigue you had felt
during exercise [18].
The heart rate was measured at the beginning and at
the end of the exercise test, which was called “HRf”, and
was obtained at the end of the running test on the
treadmill.Spirometry
The simple spirometry was used to measure lung out-
comes with pneumotachograph Fleisch DATOSPIR
120 according to the SEPAR’s criteria [20]. Three
maneuvers were performed in order to get only the
best values for the analysis. The values are deter-
mined with forced vital capacity (FVC), forced expira-
tory volume in one second (FEV1), Tiffenau index
which is the ratio between forced expiratory volume
in one second and forced vital capacity (FEV1/FVC).
The values are expressed in absolute terms in millili-
ters and as percentage of the theoretical value for
individuals of the same age, weight and height in the
reference population.Data collection
All participants received information about the research
and gave their written consent before participation. We
performed a general clinical interview which included an
exercise test and a spirometry.Data management and analysis
All analyses were conducted using SPSS version 17.0.
Kolmogorov-Smirnov tests were used to analyze the nor-
mality of the data distribution. Student’s T tests for rela-
tional samples were performed to get the differences
within each group after the intervention. We also used
Student’sT test for independent samples to get the inter-
group effect of this intervention.
Sample size
The sample size was calculated with an alpha error of
0.05, a power of 0.80 and a beta risk of 0.20 according to
the effect size of EQ-5D that it was made according to
Cohen’s criteria [21]. One hundred subjects took part in
this research against 60 individuals are needed in a priori
estimation: 30 individuals in the IG and 30 in the CG.
Evaluation of clinical relevance
Cohen’s criteria were taken into account in the analysis
of the effect size values, his criteria determine that
values below 0.2 are considered to have no effect, those
between 0.2 and 0.5 a small effect, between 0.5 and 0.8 a
medium effect, and those above 0.8 are considered to
have a huge effect [21].
Ethics
This study was authorized by the Ethics and Research
Committee of the “Costa del Sol” Health District. All
participants gave written informed consent, confidential-
ity and anonymity were also preserved at all times and
the principles of the Declaration of Helsinki were
respected.
Results
The sample consisted of thirty-one men and forty-four
women. The subjects mean aged was 62.28 ± 6.9 years.
Gender difference is reflected in all data. The initial
characteristic of the participants are shown in Table 1.
Regarding the systolic and diastolic blood pressure at
rest, the initial values of systolic blood pressure were
greater than 140 mm Hg (Table 1). The descriptive
values of the changes within each group, obtained in the
self-reported questionnaires and the cardiopulmonary
outcomes by gender difference (Table 2).
In our study, the changes between both the experi-
mental and the control group in the self-reported ques-
tionnaires found the range of EQ-5D of the male
population with a difference between groups in the ef-
fect size value of 0.05 (p = 0.05), whereas women did not
improve their quality of life. The changes between both
the experimental and control group in the cardiopul-
monary function outcome for the FEV1/FVC value did
not show statistically significant changes in the experi-
mental group, which the mean FEV1/FVC value for both
Table 1 Initial characteristic according the gender difference
Control group Intervention group
Men mean (CI) Women mean (CI) Men mean (CI) Women mean (CI)
age (years) 64.25 (59–69) 62.82(60–65) 60.50 (57–63) 63.26(60–66)
Weight (Kg) 93.29(79–106) 78.50(71–85) 87.44 (77–97) 78.21(71–85)
Height (metre) 1.68(1.64–1.72) 1.58(1.5–1.60) 1.67 (1.62–1.74) 1.56(1.54–1.59)
SPB (mm Hg) 156(143–168) 133(127–140) 144(134–154) 131(125–137)
DPB (mm Hg) 83(76–91) 78.91(75–82) 79(69–89) 80.21(76–85)
HRr (B/min) 73(66–80) 76.18(72–80) 75.17(68–82) 80.04(74–86)
HRmax (B/min) 132(127–136) 133.43(131–135) 134(130–138) 132.57(129–136)
HRf (B/min) 122(114–130) 125(118–132) 124(115–132) 123.21(115–131)
RPE 5.75(4.7–6.8) 5.27(4.50–6.04) 5.28(4.44–6.11) 5(4.42–5.58)
FVC (L) 3.78(2.9–4.6) 2.76(2.21–3.3) 3.88(3.14–4.62) 2.54(2.22–2.86)
FEV1 (L) 2.55(1.94–3.16) 1.68(1.32–2.03) 2.44(1.99–2.9) 1.77(1.51–2.02)
FEV1/FVC (%) 66.59(57–76) 68(59–78) 65.61(57–74) 71(63–79)
EQ-5D (0–1) 0.57(0.38–0.75) 0.59(0.48–0.72) 0.58(0.36–0.76) 0.53(0.40–0.67)
Physical role (0–100) 46(40–51) 44.32(40–49) 48(43–53) 42.5(37–48)
Social (0–100) 26.27(26.3–26.3) 31.71(23–40) 31.3(20.22–42.4) 25.15(18–32)
Vitality (0–100) 52.8(46–60) 49(43–55) 46.1(40–52) 51(44–57)
Mental (0–100) 34.06(26–42) 36.43(30–42) 37.5(30–44) 39(33–45)
CI: confidence interval.
SPB: systolic blood pressure.
%: percentage.
L: liter.
B/min: beats per minute.
HRr: heart rate on resting.
DPB: diastolic blood pressure.
HRf: heart rate at the end.
HRmax: maximum heart rate.
RPE: rate perceived effort.
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(Table 2). The men of the control group showed a
greater negative effect (−17.48 vs. -1.23%), compared to
women with a smaller negative effect (Table 2).
Discussion
Quality of life improved significantly for inactive subjects
who carried out the PAPP (p = 0.05). Besides, pulmonary
function outcomes FVC and FEV1/FVC values found
statistically significant differences within experimental
group. However, these differences were not found within
the control group. Other clinical trials with community
intervention programs have increased the level of phys-
ical activity, without improving the level of the quality of
life [22]. In contrast, others have improved the quality of
life without changing the level of physical activity [23].
Statistically differences were observed for people with
depression after the DeLLITE program of physical activ-
ity in the quality of mental health, measured with the
SF-36 questionnaire [24].
In previous research, the criteria established for the
minimum important differences of the ranged of EQ-5D
from 0.033 [25] to 0,074 [26]. In the current study, themale population was within this range of EQ-5D with a
difference between groups in the effect size value of 0.05
(p = 0.05), whereas women did not improve their qual-
ity of life. In cardiac patients an effect size of 0.31,
(p = 0.001) was observed in the quality of life with a
positive statistical significance [27]. However, a cross-
sectional study showed a decreased quality of life value
with respect to the EQ-5D questionnaire, in the people
aged between 66–79 years with sedentary lifestyles [28].
Furthermore, it is necessary to reach the consensus
about the clinically important difference for EQ-5D.
According to the general health status which was
determined with the SF-12 questionnaire there were no
statistically significant changes between groups, after the
intervention of the PAPP, as the current study has
shown. However, other studies showed improved cogni-
tive function (effect size 1.17) in people who performed
physical activity [29]. Like as in other studies, they found
that active subjects had fewer psychological problems
than inactive subjects [30]. Statistically also changes in
the SF-36 questionnaire had been observed after per-
forming a program of physical activity in water during
two months. These improvements were obtained in all
Table 2 Changes within each group obtained in the cardiopulmonary outcomes and the questionnaires according
gender difference
Control group Intervention group
Men mean (CI) Women mean (CI) Men mean (CI) Women mean (CI)
Weight (Kg) 1.95(0.47-3.44)** −0.63(−2.19-0.92) −0.05 (−3.13-3.02) −0.50(−1.82-0.82)
SPB (mm Hg) 13.08(0.53-25.63)* −3.13(−8.73-2.46) −4.33(−20-11.44) −4.65(−10.27-1.41)
DPB (mm Hg) 0.83(−4.83-6.49) −0.04(2.40-2.31) −4.50(−16-7.08) 1.43(−2.93-5.80)
HRr (B/min) −3.75(−9.86-2.36) −4.5(−8.45-(−0.54)* −2.16(−5.80-1.47) 1.04(−2.64-4.72)
HRmax (B/min) −0.58(−1.86-0.70) −0.09(−0.32-0.142) −0.42(−1.23-0.40) −1.78(−4.62-1.05)
HRfinal (B/min) 4(−1.92-9.92) 1.72(−4.75-8.21) 1(−6.01-8.01) 3.82(−4.09-11.74)
RPE 0.83(−0.13-1.80) 0.91(0.22-1.59)** 0.22(−0.60-1.05) 0.39(−0.29-1.07)
FVC (L) 0.82(0.33-1.31) 0.38(−0.09-0.85) 0.73(0.18-1.27)** 0.10(−0.06-0.27)
FEV1 (L) 0.06(−0.38-0.51) −0.02(−0.24-0.19) 0.11(−0.03-0.26) −0.07(−0.23-0.08)
FEV1/FVC (%) 17.47(−28.01-(−6.95) −1.22(−11.30-8.85) −10.45(−18.6-(−2.23)** 5.17(−11.45-1.11)
EQ-5D (0–1) −0.24(−0.43-0.043)* 0.065(−0.166-0.03) 0.02(−0.18-0.23) 0.14(−0.30-0.01)
Physical role (0–100) 0(−7.27-7.27) 3.43(−1.14-8.01) 1.16(−5.12-8.34) 4.29(−0.619-9.21)
Social (0–100) 10.09(−8.45-28.65) 1.12(−12.58-14.81) 10.09(−8.45-28.65) 8.07(−21.81-5.65)
Body Pain (0–100) 7.64(−0.46-15.75)* 8.33(0.95-15.72)* 5.09(−4.26-14.45) 5.09(−4.26-14.45)
General Health (0–100) 1.23(−2.69-5.16) 0.43(−3.18-2.32) 3.50(−7.58-0.58) 0.95(−3.29-1.37)
Vitality(0–100) 8.51(−1.67-18.70) 0(−5.11-5.11) 2.87(−5.15-10.90) 2.68(−5.32-10.69)
Mental(0–100) 2.03(−9.17-13.23) 3.04(−15.42-9.32) 1.74(−10.31-13.79) 6.70(−3.03-16.44)
**p = 0.01.
CI: confidence interval.
SPB: systolic blood pressure.
RPE: rate perceived effort.
*p = 0.05.
HRr: heart rate on resting.
HRf: heart rate at the end.
HRmax: maximum heart rate.
B/min: beats per minute.
%: percentage.
FEV1: forced expiratory volume.
FEV1/FVC: Tiffenau index.
FVC: forced vital capacity.
L: liter.
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role and in general health [31].
Regarding the systolic and diastolic blood pressure, we
did not observe statistically significant differences in the
effect size on diastolic blood pressure after the proced-
ure. In contrast, the effect size for cardiac subjects
showed statistically better improvement (p = 0.01) [27].
In a recent meta-analysis, both resistance training pro-
grams and isometric hand grip could help decrease
blood pressure [32]. Besides, resistance programs could
decrease the risk of cardiovascular disease [33].
There were a slight decrease in systolic blood pressure
(SDP) at rest concerning the same value in both men
and women in the experimental group (−4.33 vs. -4
.65 Mm Hg). However, men in the control group showed
an increase systolic blood pressure (13.09 vs. -3.13 Mm Hg,
p = 0.05) compared with women who showed a decrease
in systolic blood pressure. In contrast, people with mild
hypertension found a significant decrease in systolic bloodpressure, as a result of performing a program of low inten-
sity running [34].
Respect to diastolic blood pressure (DBP) not statisti-
cally significant changes were found within each group.
There was a decrease in DBP in men in the experimental
group (−4.5 vs. 1.43 mm Hg) versus a slight increase in
DBP in women (Table 2). However, people with hyper-
tension got statistically significant decrease after receiv-
ing a program of low intensity exercise [34]. Women
with metabolic syndrome also got decrease both blood
pressures when performed a program of low intensity
[35]. Besides, a decrease in blood pressure has been
observed after performed a program of moderate inten-
sity resistance exercises [36].
According to the cardiac outcomes not statistically sig-
nificant changes were found between both the experimen-
tal and control group. However, we found statistically
significant changes in resting HR in the control group of
women. The mean HR value was (−3.75 vs. -4.5, p = 0.05)
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tistically significant changes were not observed in the
experimental group (Table 2). There are studies that
found differences in the cardiac function depending on
the amount of body fat of the subject [37]. The Fit &
Firm program showed significant improvement in heart
rate [38]. It could be possible that the cardiac function
response depends on a mix of genetic factor and the
intensity of training.
The pulmonary outcomes except FEV1 improved sig-
nificantly (p < 0.01) in men of the experimental group. In
a recent study, all pulmonary function parameters except
FEV1/FVC improved significantly (p < 0.0001) in both
yoga and swimming groups [39]. Besides, better pulmon-
ary functions in subjects performing yoga as well as
swimming are documented [4,40]. Statistically significant
changes in pulmonary function of FEV1/FVC and FEV1
values in people who performed regularly physical activ-
ity compared with sedentary people were shown [4].
Apart from that, the participants performed a four-week
program who found statistically significant changes in
FEV1 and FEV1/FVC (3.96 vs. 0.96, p = 0.001), but there
were no statistically significant changes in the FVC value
(4.13, p = 0.43) [39]. This program included upper limb
resistive exercises for thirty minutes, supplemented with
ten minutes of breathing exercises [39]. Nevertheless,
the program “Exercise on Prescription” not found effect
on the pulmonary outcome in the physical inactive
women in the Netherlands [41].
Type II error should take into account the outcomes
which did not show effects due to lack of subjects. Fu-
ture studies will be necessary to find the reason to ex-
plain the difference in FVC and FEV1/FVC outcomes
between men and women [5].
Conclusions
Changes statistically significant in the quality of life mea-
sured with EQ-5D in the group of men who carried out
the PAPP when comparing between groups. However
changes in cardiopulmonary function were not as rele-
vant when comparing between groups. On the contrary,
there was a significant effect within each group in the
pulmonary outcomes of values in men, within the ex-
perimental group.
To ensure the quality of this randomized clinical
trial the guide developed by the CONSORT statement
(Consolidated Standards of Reporting Trials) [42] has
been followed. ClinicalTrials.gov ID: NCT01172483.
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